NFKB1/NFKBIa polymorphisms are associated with the progression of cervical carcinoma in HPV-infected postmenopausal women from rural area

Tumor Biology

Volumn 36, Issue 8, 2015, Pages 6265-6276

  Pallavi, Singhal ^a,b   Anoop, Kumar ^a   Showket, Hussain ^a   Alo, Nag ^b   Mausumi, Bharadwaj ^a  

^a INSTITUTE OF CYTOLOGY AND PREVENTIVE ONCOLOGY   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

Cervical cancer; HPV; NFKB1; NFKBIa; Polymorphism

Indexed keywords

3' UNTRANSLATED REGION; ADULT; AGE; ALLELE; ARTICLE; CANCER GROWTH; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; INDIA; MAJOR CLINICAL STUDY; MIDDLE AGED; NFKB1 GENE; NFKBIA GENE; PAPILLOMAVIRUS INFECTION; PARITY; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PREGNANCY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; RURAL AREA; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TOBACCO CONSUMPTION; UTERINE CERVIX CARCINOMA; AGED; CARCINOMA; GENETIC PREDISPOSITION; GENETICS; PAPILLOMAVIRIDAE; PATHOGENICITY; PATHOLOGY; UTERINE CERVIX TUMOR;

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NFKB1 PROTEIN, HUMAN;

ADULT; AGED; ALLELES; CARCINOMA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; NF-KAPPA B P50 SUBUNIT; PAPILLOMAVIRIDAE; POLYMORPHISM, SINGLE NUCLEOTIDE; UTERINE CERVICAL NEOPLASMS;

EID: 84940439869     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3312-7     Document Type: Article

References (40)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11; 2013.
2. Zur HH. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342–50.
3. Kohaar I, Thakur N, Salhan S, Batra S, Singh V, Sharma A, et al. TNFalpha-308G/A polymorphism as a risk factor for HPV associated cervical cancer in Indian population. Cell Oncol. 2007;29:249–56.
4. Hinkula M, Pukkala E, Kyyronen P, Laukkanen P, Koskela P, Paavonen J, et al. A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland. Br J Cancer. 2004;90:1025–9.
5. Kjellberg L, Hallmans G, Ahren AM, Johansson R, Bergman F, Wadell G, et al. Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer. 2000;82:1332–8.
6. Santoro MG, Rossi A, Amici C. NF-kappaB and virus infection: who controls whom. EMBO J. 2003;22:2552–60.
7. Karin M, Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002;2:301–10.
8. Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol. 2002;2:725–34.
9. Sethi G, Sung B, Aggarwal BB. Nuclear factor-kappaB activation: from bench to bedside. Exp Biol Med (Maywood). 2008;233:21–31.
10. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature. 2004;431:461–6.
11. James MA, Lee JH, Klingelhutz AJ. Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner. J Virol. 2006;80:5301–7.
12. Du CX, Wang Y. Expression of P-Akt, NFkappaB and their correlation with human papillomavirus infection in cervical carcinoma. Eur J Gynaecol Oncol. 2012;33:274–7.
13. Nair A, Venkatraman M, Maliekal TT, Nair B, Karunagaran D. NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix. Oncogene. 2003;22:50–8.
14. Sambrook Ra. Molecular Cloninig: a laboratory manual; Cold Spring Harbor Laboratory Press 3, 2001.
15. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988;239:487–91.
16. Senol TS, Okyay P, Bardakci F. Identification of NF-kappaB1 and NF-kappaBIAlpha polymorphisms using PCR-RFLP assay in a Turkish population. Biochem Genet. 2010;48:104–12.
17. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 1986;46:705–16.
18. Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ, Bailey-Wilson JE, et al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet. 2004;13:35–45.
19. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa] B activity. Annu Rev Immunol. 2000;18:621–63.
20. Bianco B, Lerner TG, Trevisan CM, Cavalcanti V, Christofolini DM, Barbosa CP. The nuclear factor-kB functional promoter polymorphism is associated with endometriosis and infertility. Hum Immunol. 2012;73:1190–3.
21. Burnik FS, Yalcin S. NFKB1–94 insertion/deletion ATTG polymorphism in gastroenteropancreatic neuroendocrine tumors. Chemotherapy. 2009;55:381–5.
22. Cheng CW, Su JL, Lin CW, Su CW, Shih CH, Yang SF, et al. Effects of NFKB1 and NFKBIA gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathological features. PLoS One. 2013;8:e56130.
23. Lin CW, Hsieh YS, Hsin CH, Su CW, Lin CH, Wei LH, et al. Effects of NFKB1 and NFKBIA gene polymorphisms on susceptibility to environmental factors and the clinicopathologic development of oral cancer. PLoS One. 2012;7:e35078.
24. Mishra A, Srivastava A, Mittal T, Garg N, Mittal B. Role of inflammatory gene polymorphisms in left ventricular dysfunction (LVD) susceptibility in coronary artery disease (CAD) patients. Cytokine. 2013;61:856–61.
25. Mohd Suzairi MS. Tan SC, hmad Aizat AA, Mohd AM, Siti Nurfatimah MS, Andee ZD, Ankathil R: The functional −94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer. Cancer Epidemiol. 2013;37:634–8.
26. Tang T, Cui S, Deng X, Gong Z, Jiang G, Wang P, et al. Insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for superficial bladder cancer in Chinese. DNA Cell Biol. 2010;29:9–12.
27. Yalcin B, Atakan N, Alli N. The functional role of nuclear factor kappa-kappaB1–94 ins/del ATTG promotor gene polymorphism in Behcet’s disease: an exploratory study. Clin Exp Dermatol. 2008;33:629–33.
28. Zhang D, Li L, Zhu Y, Zhao L, Wan L, Lv J, et al. The NFKB1–94 ATTG insertion/deletion polymorphism (rs28362491) contributes to the susceptibility of congenital heart disease in a Chinese population. Gene. 2013;516:307–10.
29. Zhou B, Rao L, Li Y, Gao L, Wang Y, Chen Y, et al. A functional insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for nasopharyngeal carcinoma. Cancer Lett. 2009;275:72–6.
30. Zhou B, Qie M, Wang Y, Yan L, Zhang Z, Liang A, et al. Relationship between NFKB1–94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk. Ann Oncol. 2010;21:506–11.
31. Zhou B, Rao L, Peng Y, Wang Y, Qie M, Zhang Z, et al. A functional promoter polymorphism in NFKB1 increases susceptibility to endometriosis. DNA Cell Biol. 2010;29:235–9.
32. Arisawa T, Tahara T, Shiroeda H, Yamada H, Nomura T, Hayashi R, et al. NFKB1 polymorphism is associated with age-related gene methylation in Helicobacter pylori-infected subjects. Int J Mol Med. 2012;30:255–62.
33. Arisawa T, Tahara T, Shiroeda H, Yamada K, Nomura T, Yamada H, et al. Functional promoter polymorphisms of NFKB1 influence susceptibility to the diffuse type of gastric cancer. Oncol Rep. 2013;30:3013–9.
34. Gao J, Xu HL, Gao S, Zhang W, Tan YT, Rothman N, et al. Genetic polymorphism of NFKB1 and NFKBIA genes and liver cancer risk: a nested case–control study in Shanghai. China BMJ Open. 2014;4:e004427.
35. Bu H, Rosdahl I, Sun XF, Zhang H. Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients. J Cancer Res Clin Oncol. 2007;133:859–66.
36. Gao J, Pfeifer D, He LJ, Qiao F, Zhang Z, Arbman G, et al. Association of NFKBIA polymorphism with colorectal cancer risk and prognosis in Swedish and Chinese populations. Scand J Gastroenterol. 2007;42:345–50.
37. Huang D, Yang L, Liu Y, Zhou Y, Guo Y, Pan M, et al. Functional polymorphisms in NFkappaB1/IkappaBalpha predict risks of chronic obstructive pulmonary disease and lung cancer in Chinese. Hum Genet. 2013;132:451–60.
38. Song S, Chen D, Lu J, Liao J, Luo Y, Yang Z, et al. NFkappaB1 and NFkappaBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese population. PLoS One. 2011;6:e21726.
39. Umar M, Upadhyay R, Kumar S, Ghoshal UC, Mittal B. Association of common polymorphisms inTNFA, NFkB1 and NFKBIA with risk and prognosis of esophageal squamous cell carcinoma. PLoS One. 2013;8:e81999.
40. Koc A, Batar B, Celik O, Onaran I, Tasan E, Sultuybek GK. Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population. Immunobiology. 2014;219:531–6.